Mayo Clinic Q&A: Cardiac Risks of Off-Label Drugs to Treat COVID-19

Everyone
  • 1 video | 15m 50s
A study published recently in Mayo Clinic Proceedings details information about potential cardiac side effects when using off-label drugs to treat COVID-19. Off-label means the drug has been approved by the Food and Drug Administration to treat a different condition. Some of the off-label drugs being used to treat COVID-19 have a risk of sudden cardiac arrest and death. (Published 04/08/2020)

YOU MIGHT ALSO LIKE

Course Mayo Clinic Q&A: Managing COVID-19 Inpatients
Course Mayo Clinic COVID-19 Live Webinar Series - December 8, 2020: Leadership Strategies for 2021
Course Mayo Clinic Q&A: Looking Back and Moving Forward with Patient Care During COVID-19

PEOPLE WHO VIEWED THIS ALSO VIEWED THESE

Course Mayo Clinic Q&A: News Briefing with Dr. Poland
Course Mayo Clinic Q&A: Isolation, Stress and the Pandemic Affecting Those With Eating Disorders
Course Mayo Clinic Q&A: Opioid Crisis Worsens During COVID-19 Pandemic